All for Joomla All for Webmasters

Author: admin

St. Louis-Based Precision Virologics Receives $500,000 Investment in Biologically Targeted Vaccines for Zika and Chikungunya

St. Louis, MO (March 29, 2017) – Precision Virologics today announced a $500,000 investment from Oncolys BioPharma, a publicly traded Japanese company focusing on the development of novel viral-based biologics for the treatment of cancer and serious infectious diseases. This investment signals global interest in the St. Louis-based Precision, which is developing biologically targeted vaccines […]

Read More

Precision Virologics Enters License Agreement with Washington University to Develop Biologically Targeted Vaccines for Zika and Chikungunya

Saint Louis, MO – March 21, 2017 – Precision Virologics, a biotech company developing biologically targeted vaccines for emerging infectious diseases, today announced that the company has entered a license agreement with the Office of Technology Management, the tech transfer arm of Washington University. “Precision’s technology will provide the next-generation vaccines for emerging infectious diseases. […]

Read More